ACCORD HEALTHCARE, INC. recalls
34 federal recalls on file, showing the 14 from the last 12 months. We monitor every CPSC, FDA, USDA, and NHTSA notice for ACCORD HEALTHCARE, INC. and translate it into plain English — free weekly digest, optional same-day alerts.
- 2026-09-02FDA-DrugClass IIAccord Levothyroxine 300 mcg tablets recalled for subpotency
Accord Healthcare is recalling one lot of Levothyroxine Sodium 300 mcg tablets because they may contain less active ingredient than labeled. Levothyroxine is a thyroid medication, and subpotent tablets may not work as intended to treat thyroid conditions.
- 2026-09-02FDA-DrugClass IIAccord levothyroxine 200 mcg tablets recalled for subpotency
Accord Healthcare is recalling specific lots of levothyroxine sodium 200 mcg tablets because they contain less active ingredient than labeled. This means the medication may not work as intended for patients taking it to treat thyroid conditions.
- 2026-09-02FDA-DrugClass IIAccord Healthcare Levothyroxine 175 mcg recalled for subpotency
Accord Healthcare is recalling specific lots of Levothyroxine Sodium Tablets 175 mcg because they may contain less active ingredient than labeled. Levothyroxine is a thyroid hormone replacement medication, and tablets that are weaker than expected could result in inadequate treatment of thyroid conditions.
- 2026-09-02FDA-DrugClass IIAccord levothyroxine tablets recalled for being subpotent
Accord Healthcare is recalling specific lots of levothyroxine sodium 150 mcg tablets because they may contain less active ingredient than labeled. Levothyroxine is a thyroid replacement medication, and subpotent tablets could result in inadequate thyroid hormone levels in patients who depend on this drug.
- 2026-09-02FDA-DrugClass IIAccord Healthcare levothyroxine tablets recalled for lower potency
Accord Healthcare is recalling certain batches of levothyroxine sodium 137 mcg tablets because they contain less active ingredient than labeled. Levothyroxine is a thyroid medication, and tablets that are weaker than expected may not effectively treat hypothyroidism. The recall affects 90-count and 1000-count bottles distributed nationwide.
- 2026-09-02FDA-DrugClass IIAccord Levothyroxine 125 mcg tablets recalled for reduced potency
Accord Healthcare is recalling specific lots of Levothyroxine Sodium 125 mcg tablets because they may contain less active ingredient than labeled. This means the medication may not work as intended for patients taking it to manage thyroid conditions.
- 2026-09-02FDA-DrugClass IIAccord Healthcare levothyroxine tablets recalled for reduced potency
Accord Healthcare is recalling specific lots of levothyroxine sodium 112 mcg tablets because they contain less active ingredient than labeled. This means patients taking these tablets may not receive the full thyroid hormone dose they need. The recall affects 1000-count bottles distributed nationwide.
- 2026-09-02FDA-DrugClass IIAccord levothyroxine tablets recalled for subpotency risk
Accord Healthcare is recalling certain batches of levothyroxine sodium 100 mcg tablets because they may contain less active ingredient than labeled. This affects patients who rely on consistent thyroid hormone dosing. The affected lots were distributed nationwide.
- 2026-09-02FDA-DrugClass IIAccord levothyroxine tablets recalled for subpotent drug
Accord Healthcare is recalling certain batches of levothyroxine sodium 88 mcg tablets because they may contain less active ingredient than labeled. This means the medication may not work as intended for patients who depend on it to manage thyroid conditions.
- 2026-09-02FDA-DrugClass IIAccord Healthcare levothyroxine tablets recalled for reduced potency
Accord Healthcare is recalling specific lots of levothyroxine sodium 75 mcg tablets because the tablets contain less active ingredient than labeled. Levothyroxine is a thyroid hormone replacement medication, and subpotent doses may not adequately treat thyroid conditions. The affected lots are D2402016 and D2402017, expiring 08/31/2026.
- 2026-09-02FDA-DrugClass IIAccord levothyroxine tablets recalled for subpotent content
Accord Healthcare is recalling specific lots of levothyroxine sodium 50 mcg tablets because they contain less active ingredient than labeled. This means the medication may not work as intended for patients who depend on it to manage thyroid conditions.
- 2026-09-02FDA-DrugClass IIAccord Healthcare levothyroxine tablets recalled for subpotency
Accord Healthcare is recalling specific lots of levothyroxine sodium tablets (25 mcg) because they contain less active ingredient than labeled. Patients taking these tablets may not receive the full dose needed to manage their thyroid condition. The affected lots were distributed nationwide.
- 2026-07-08FDA-DrugClass IIAccord levothyroxine tablets recalled for subpotency
Accord Healthcare is recalling one lot of levothyroxine sodium 300 mcg tablets because they may contain less active ingredient than labeled. This means the medication may not work as intended for patients who need it to manage thyroid conditions.
- 2025-10-15FDA-DrugClass IILevothyroxine Sodium Tablets, USP, 88 mcg (0.088 mg), 90 Tablets per bottle, Rx Only, Manufactured for Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: Intas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, India, NDC 16729-450-15.
Subpotent: During long term stability testing of Levothyroxine Sodium Tablets USP for 88 mcg, the assay content was observed below the approved specification range.
Get the week's recalls, including ACCORD HEALTHCARE, INC.
Free weekly digest — every federal recall affecting your household, ACCORD HEALTHCARE, INC. included when it comes up. Track ACCORD HEALTHCARE, INC. specifically with Always-on.